Medical News

RSS

Naviscan announces presentations on PEM technology at Society of Nuclear Medicine Annual Meeting

Naviscan's Positron Emission Mammography (PEM) technology was the focus of several presentations and discussions at the Society of Nuclear Medicine Annual Meeting in Salt Lake City. The focus represents a growing interest and validation of how PEM can play an important role in the fight against breast cancer.

18 Jun 2010

National Cheng Kung University Hospital's Outpatient Building inaugurated

The Outpatient Building of National Cheng Kung University Hospital was officially inaugurated on June 12th to provide excellent medical service and to further ensure the health of people in Southern Taiwan.

18 Jun 2010

Neupro improves wellbeing impaired by pain related to Restless Legs Syndrome

The first data to show that Neupro® (rotigotine transdermal system) significantly improved wellbeing and daily activities that are often impaired by pain related to Restless Legs Syndrome (RLS) were presented this week at the 14th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.

18 Jun 2010

General practitioners exchange knowledge, experience via e-mail list started in 1999

Urban Carlén, Department of Applied Information Technology, has studied how a large group of general practitioners interact via an e-mail list. The list started in 1999 and serves as an online community for exchange of knowledge and experience. The submitted e-mails are distributed to all members of the community.

18 Jun 2010

Additional positive data from Ardea Biosciences' RDEA594 Phase 2 program presented at EULAR

Ardea Biosciences, Inc. announced that additional positive data from its Phase 2 program for RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, are being presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in Rome, Italy. RDEA594, a first-in-class selective inhibitor of the URAT1 transporter, treats the underlying cause of gout by increasing the excretion of uric acid in order to bring the body's levels of uric acid into a normal range.

18 Jun 2010

Children's Hospital Boston receives $2.4M Gates Foundation grant to develop novel neonatal vaccines

Children's Hospital Boston announced today that it has received a $2.4 million grant from the Bill & Melinda Gates Foundation. The grant will support the development of novel vaccines for newborns – research that is spearheaded by Ofer Levy, MD, Ph.D., a principal investigator in the Division of Infectious Diseases at Children's.

18 Jun 2010

Walgreens reaches agreement with CVS Caremark on participation in PBM national retail network

CVS Caremark Corporation and Walgreens today announced that the companies have reached an agreement on terms under which Walgreens will continue participating in the CVS Caremark pharmacy benefit management (PBM) national retail network for existing, new or renewal plans. The companies are not disclosing the financial terms of the new contract.

18 Jun 2010

AHRQ: Only 57% of U.S. men see doctor for routine care compared to 74% of women

Just over half of U.S. men (57 percent) see a doctor, nurse practitioner or physician assistant for routine care, compared to nearly three-quarters (74 percent) of women, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. Routine care is typically defined as a visit for assessing overall health rather than one prompted by a specific illness or complaint.

18 Jun 2010

Genzyme signs repurchase agreement with Goldman, Sachs

Genzyme Corporation announced today that it has entered into an agreement with Goldman, Sachs & Co. to repurchase $1 billion of Genzyme common stock under an accelerated stock repurchase program. Proceeds from its recently concluded debt offering will be used to support this first tranche of Genzyme's overall $2 billion share repurchase plan announced in May.

18 Jun 2010

St. Jude Medical's Therapy Cool Flex Ablation Catheter granted European CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of the Therapy™ Cool Flex™ Ablation Catheter at the 17th World Congress in Cardiac Electrophysiology and Cardiac Techniques (CardioStim). The ablation catheter is the industry's first to have a fully-irrigated and flexible tip, which can potentially improve the safety and efficacy of cardiac ablation procedures.

18 Jun 2010

Matrix Laboratories receives FDA approval for generic version Zocor Tablets: Mylan

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Simvastatin Tablets USP, 5 mg, 10 mg, 20 mg, 40 mg and 80 mg, the generic version of Merck & Co.'s Zocor Tablets, a treatment for high cholesterol. The product will be distributed by Mylan Pharmaceuticals Inc.

18 Jun 2010

Precision announces USPTO's issuance of Actions Closing Prosecution in reexamination proceedings for '545, '605 patents

Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has now issued Actions Closing Prosecution in the reexamination proceedings for both U.S. Pat. No. 6,610,545 ("the '545 patent") and U.S. Pat. No. 7,309,605 ("the '605 patent") that are owned by the Institut Pasteur and the Universite Pierre et Marie Curie (UPMC), and licensed to Cellectis, SA (ALCLS).

18 Jun 2010

Cyclacel files Answer and Counterclaims to Celgene's declaratory judgment complaint

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it filed its Answer and Counterclaims to the declaratory judgment complaint filed by Celgene Corporation.

18 Jun 2010

Research on evolution of malaria parasite to develop improved control strategies

An international team, led by researchers at Imperial College London, have found that the potentially deadly tropical disease evolved alongside anatomically modern humans and moved with our ancestors as they migrated out of Africa around 60-80,000 years ago. The research is published in the journal Current Biology.

18 Jun 2010

UCSB physicists create microscopic device to help biologists understand protein folding

Physicists at UC Santa Barbara have created a microscopic device to assist biologists in making very fast molecular measurements that aid the understanding of protein folding. This development may help elucidate biological processes associated with diseases such as Alzheimer's and Parkinson's. Since proteins in the body perform different functions according to their shape, the folding process is considered a key area of study.

18 Jun 2010

9th INT'L BIO FORUM & BIO EXPO JAPAN from June 30 - July 2, 2010

9th INT'L BIO FORUM & BIO EXPO JAPAN, organized by Reed Exhibitions Japan, will come back again as Asia's largest bio-event from June 30 - July 2, 2010. "Gene diagnosis" is one of the featured topics for this year.

18 Jun 2010

Gladstone Institute researcher to receive Kyoto Prize in Advanced Technology

The non-profit Inamori Foundation (President: Dr. Kazuo Inamori) today announced that Dr. Shinya Yamanaka will receive its 26th annual Kyoto Prize in Advanced Technology, which for 2010 focuses on the fields of Biotechnology and Medical Technology. Dr. Yamanaka, 47, will receive the award for his pioneering work in developing a technology to generate pluripotent stem cells that does not require the use of human embryos.

18 Jun 2010

Inspire's TIGER-1 Phase 3 clinical trial data with denufosol for CF presented at 33rd ECFS

Inspire Pharmaceuticals, Inc. announced today that data is being presented on denufosol tetrasodium, an investigational therapy for cystic fibrosis (CF), during an oral presentation and poster presentations at the 33rd Annual European Cystic Fibrosis Society (ECFS) Conference June 16 - 19, 2010 in Valencia, Spain.

18 Jun 2010

SLE and RA negatively affect patients' emotional relationships, sex lives: Study

Systemic Lupus Erythematosus patients from Brazil and Rheumatoid Arthritis patients from France report that their rheumatic conditions negatively affect their emotional relationships and sex lives, according to research presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy.

18 Jun 2010

PCPCC welcomes Obama's announcement to promote primary care workforce training

The Patient-Centered Primary Care Collaborative welcomed the announcement today by the Obama administration that some $250 million in new funding will be put towards funding of primary care workforce training.

18 Jun 2010

Medical News

Naviscan announces presentations on PEM technology at Society of Nuclear Medicine Annual Meeting

National Cheng Kung University Hospital's Outpatient Building inaugurated

Neupro improves wellbeing impaired by pain related to Restless Legs Syndrome

General practitioners exchange knowledge, experience via e-mail list started in 1999

Additional positive data from Ardea Biosciences' RDEA594 Phase 2 program presented at EULAR

Children's Hospital Boston receives $2.4M Gates Foundation grant to develop novel neonatal vaccines

Walgreens reaches agreement with CVS Caremark on participation in PBM national retail network

AHRQ: Only 57% of U.S. men see doctor for routine care compared to 74% of women

Genzyme signs repurchase agreement with Goldman, Sachs

St. Jude Medical's Therapy Cool Flex Ablation Catheter granted European CE Mark approval

Matrix Laboratories receives FDA approval for generic version Zocor Tablets: Mylan

Precision announces USPTO's issuance of Actions Closing Prosecution in reexamination proceedings for '545, '605 patents

Cyclacel files Answer and Counterclaims to Celgene's declaratory judgment complaint

Research on evolution of malaria parasite to develop improved control strategies

UCSB physicists create microscopic device to help biologists understand protein folding

9th INT'L BIO FORUM & BIO EXPO JAPAN from June 30 - July 2, 2010

Gladstone Institute researcher to receive Kyoto Prize in Advanced Technology

Inspire's TIGER-1 Phase 3 clinical trial data with denufosol for CF presented at 33rd ECFS

SLE and RA negatively affect patients' emotional relationships, sex lives: Study

PCPCC welcomes Obama's announcement to promote primary care workforce training

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News